Definium reports positive Phase 3 results for DT120 ODT
Definium reported topline results for DT120 ODT in generalized anxiety disorder, while maintaining over $1 billion in cash. The company also received FDA designation for major depressive disorder.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
START FREE — 10,000 calls/day, no key needed